NORWEGIAN PHARMA AS

4331 ÅLGÅRD

Finances

Share Ownership

Return on Equity

31,05 %

Current Ratio

3,8

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	10 862 000	11 396 000	15 872 000	15 588 000
Net Income	1 574 000	1 845 000	3 788 000	3 688 000
Total Assets	6 880 000	9 056 000	13 377 000	11 998 000
Total Equity	5 070 000	7 496 000	11 652 000	7 863 000

Income (NOK)	2022	2021	2020	2019
Revenue	10 862 000	11 396 000	15 872 000	15 588 000
Expenditure	8 840 000	9 036 000	11 067 000	10 851 000
Operating Profit	2 022 000	2 359 000	4 804 000	4 738 000
Financial Income	42 000	61 000	174 000	78 000
Financial Costs	42 000	51 000	117 000	56 000
Financial Balance	0	10 000	57 000	22 000
Earnings Before Tax	2 022 000	2 368 000	4 862 000	4 760 000
Tax	448 000	524 000	1 073 000	1 073 000
Net Income	1 574 000	1 845 000	3 788 000	3 688 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	0	0
Total Current Assets	6 880 000	9 056 000	13 377 000	11 998 000
Total Assets	6 880 000	9 056 000	13 377 000	11 998 000
Total Retained Equity	4 970 000	7 396 000	11 552 000	7 763 000
Total Equity	5 070 000	7 496 000	11 652 000	7 863 000
Total Long-Term Debt	0	2 000	0	0
Total Current Debt	1 810 000	1 558 000	1 725 000	4 135 000
Total Equity and Debt	6 880 000	9 056 000	13 377 000	11 998 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	10 862 000	11 396 000	15 872 000	15 588 000
Other Income	0	0	0	0
Revenue	10 862 000	11 396 000	15 872 000	15 588 000
Cost of Goods Sold	6 355 000	6 336 000	8 698 000	8 271 000
Salary Costs	1 248 000	1 225 000	1 231 000	1 231 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	8 840 000	9 036 000	11 067 000	10 851 000
Operating Profit	2 022 000	2 359 000	4 804 000	4 738 000
Financial Income	42 000	61 000	174 000	78 000
Financial Costs	42 000	51 000	117 000	56 000
Financial Balance	0	10 000	57 000	22 000
Dividends	4 000 000	6 000 000	0	4 500 000
Net Income	1 574 000	1 845 000	3 788 000	3 688 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	5 117 000	7 659 000	10 859 000	10 627 000
Total Current Assets	6 880 000	9 056 000	13 377 000	11 998 000
Total Assets	6 880 000	9 056 000	13 377 000	11 998 000
Total Equity	5 070 000	7 496 000	11 652 000	7 863 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	2 000	0	0
Creditors	633 000	785 000	387 000	824 000
Unpaid Taxes	111 000	132 000	109 000	108 000
Dividends	4 000 000	6 000 000	0	4 500 000
Other Current Debt	617 000	119 000	156 000	130 000
Total Current Debt	1 810 000	1 558 000	1 725 000	4 135 000
Total Equity and Debt	6 880 000	9 056 000	13 377 000	11 998 000

Financial indicators	2022	2021	2020	2019
Return on Equity	31,05 %	24,61 %	32,51 %	46,9 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	18,62 %	20,7 %	30,27 %	30,4 %
Current Ratio	3,8	5,81	7,75	2,9
Quick Ratio	3,8	5,81	7,75	2,9
Equity Ratio	0,74	0,83	0,87	0,66
Gross Profit Margin	41,49 %	44,4 %	45,2 %	46,94 %